(126 days)
Not Found
No
The summary describes a device using ultrasound and saline for tissue dissection and wound debridement. There is no mention of AI, ML, image processing, or any data-driven algorithms. The predicate devices are also ultrasonic or hydrosurgery systems without apparent AI/ML components.
Yes
The device is described as being used for "selective dissection and fragmentation of tissue, wound debridement... and cleansing irrigation of the site," indicating its use in treating wounds and tissues, which aligns with the definition of a therapeutic device.
No
The device description indicates its purpose is for tissue dissection, fragmentation, wound debridement, and cleansing irrigation, which are therapeutic actions, not diagnostic ones. It is used to remove tissue and debris, not to identify or characterize disease.
No
The device description explicitly states the system "uses ultrasound" and "saline for irrigation," indicating the presence of hardware components beyond just software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use describes a procedure performed directly on a patient's tissue (dissection, fragmentation, debridement, irrigation). This is a therapeutic or surgical intervention, not a diagnostic test performed on samples taken from the body.
- Device Description: The device uses ultrasound and saline for direct interaction with tissue and wounds. This aligns with a therapeutic or surgical device, not a device that analyzes biological samples.
- Lack of IVD Characteristics: The description does not mention any analysis of biological samples (blood, urine, tissue samples, etc.) or the use of reagents, which are typical characteristics of IVD devices.
IVD devices are used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This device's function is to physically interact with and treat tissue.
N/A
Intended Use / Indications for Use
Selective dissection and fragmentation of tissue, wound debridement (acute and chro ic wounds, burns, diseased or necrotic tissue), and cleansing irrigation of the site for the remo al of debris, exudates, fragments, and other matter.
Product codes
FQH; LFL; NRB
Device Description
The AR1000 system uses ultrasound for selective tissue dissection and fragmentation and saline for irrigation of the wound bed over course of treatment.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Not Found
Key Metrics
Not Found
Predicate Device(s)
K050776, K012753, K060782, K050129
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
N/A
0
510(k) Summary AR1000 Arobella Medical, LLC
JAN - 3 2007 K062544 1/2
510(k) Summary
The following 510(k) summary has been prepared pursuant to requirements specified in 21CFR 807.92(a).
807.92(a)(1)
Submitter Information
Allison Scott 11460 N. Meridian St., Suite 150 Carmel, IN 46032 Phone: (317) 569-9500 x106 Facsimile: (317) 569-9520
Contact Person: Allison Scott
Date: August 29, 2006
807.92(a)(2)
Trade Name: | AR1000 Ultrasonic Wound Therapy System |
---|---|
Common Name: | Ultrasonic Wound Therapy System |
Classification Name(s): | Jet Lavage; Ultrasonic Surgical Instrument |
Classification Number: | FQH; LFL; NRB |
807.92(a)(3)
Predicate Device(s)
Misonix, Inc. | SonicOne Ultrasonic Wound Debridement System | K050776 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Soring Gmbh | Sonoca 180 Ultrasound Dissection | K012753 | Treatment | |||||||
Setting | Treatment | |||||||||
Variable | Agent | |||||||||
Mechanism | Agent | |||||||||
Delivery | Device Agent | 510(K) or PMA | ||||||||
Submission/ | ||||||||||
CFR Citation | Indications For | |||||||||
Use | COMPARISON | |||||||||
TABLE | ||||||||||
Smith & Nephew | VersaJet Hydrosurgery System | K060782 | Hospital, clinic, in- | |||||||
home, or | ||||||||||
intraoperative settings | Applicator size/ | |||||||||
positioning/contact- | ||||||||||
surface, frequency | ||||||||||
and duration of | ||||||||||
treatments; irrigation | ||||||||||
flow rate | Ultrasound for | |||||||||
selective tissue | ||||||||||
dissection and | ||||||||||
fragmentation and | ||||||||||
irrigation of wound | ||||||||||
bed over course of | ||||||||||
treatment | Irrigation & Contact | |||||||||
Probe | High Intensity | |||||||||
Ultrasound & Irrigation | ||||||||||
35kHz / ? | To Be Submitted | Selective dissection & | ||||||||
fragmentation of tissue | ||||||||||
wound debridement | ||||||||||
(acute and chronic | ||||||||||
wounds, burns, | ||||||||||
diseased or necrotic | ||||||||||
tissue), and cleansing | ||||||||||
irrigation of the site for | ||||||||||
the removal of debris, | ||||||||||
exudates, fragments, | ||||||||||
and other matter. May | ||||||||||
promote healing of | ||||||||||
wound or tissue. | Arobella Medical | |||||||||
AR1000 Ultrasonic | ||||||||||
Wound Therapy | ||||||||||
System | ||||||||||
Celleration | Celleration Mist Therapy System | K050129 | Hospital, clinic, in- | |||||||
home, or | ||||||||||
intraoperative | ||||||||||
settings | Applicator size/ | |||||||||
positioning, | ||||||||||
frequency and | ||||||||||
duration of | ||||||||||
treatments | General cavitation | |||||||||
(thermal agitation | ||||||||||
and fragmentation) | ||||||||||
of wounds and | ||||||||||
tissues | Contact Probe | High Intensity | ||||||||
Ultrasound | ||||||||||
22.5kHz / ? | K050776 | |||||||||
(AUSS-6 Ultrasonic | ||||||||||
Surgical Aspirator | ||||||||||
System) | Ultrasonic | |||||||||
debridement of | ||||||||||
wounds (including | ||||||||||
burns, diabetic | ||||||||||
ulcers, bedsores, | ||||||||||
and vaginal ulcers), | ||||||||||
soft tissues, and | ||||||||||
cleansing surgical | ||||||||||
sites | Misonix | |||||||||
(www.misonix.com) | ||||||||||
SonicOne™ | ||||||||||
Ultrasonic Wound | ||||||||||
Debridement | ||||||||||
System | ||||||||||
Intraoperative | ||||||||||
setting | Applicator size/ | |||||||||
positioning, | ||||||||||
frequency and | ||||||||||
duration of | ||||||||||
treatments | General cavitation | |||||||||
(thermal agitation | ||||||||||
and fragmentation) | ||||||||||
of wounds and | ||||||||||
tissues | Contact Probe | High Intensity | ||||||||
Ultrasound | ||||||||||
25kHz / ? | K012753 | Selected dissection | ||||||||
and fragmenting of | ||||||||||
tissue at the | ||||||||||
operation site | ||||||||||
during multi-medical | ||||||||||
discipline surgery | ||||||||||
(General Surgery, | ||||||||||
Neuro, Thoracic, | ||||||||||
Urology, and | ||||||||||
Gastro-intestinal) | Soring Gmbh | |||||||||
Medizintechnik | ||||||||||
(www.soering.com) | ||||||||||
Sonoca 180 | ||||||||||
Ultrasound | ||||||||||
Dissection | ||||||||||
Hospital, clinic, or | ||||||||||
in-home settings | Applicator | |||||||||
positioning, | ||||||||||
frequency and | ||||||||||
duration of | ||||||||||
treatments; Mist | ||||||||||
flow rate | Ultrasound wound | |||||||||
cleansing and | ||||||||||
maintenance | ||||||||||
debridement | Atomized Irrigant & | |||||||||
Non-Contact Probe | High Intensity | |||||||||
Ultrasound | ||||||||||
40kHz / ? | K032378 / K050129 | Promotes wound | ||||||||
healing through | ||||||||||
wound cleansing | ||||||||||
and maintenance | ||||||||||
debridement | ||||||||||
by the removal of | ||||||||||
yellow slough, fibrin, | ||||||||||
tissue exudates | ||||||||||
and bacteria | Celleration | |||||||||
(www.celleration.co | ||||||||||
m) Mist Therapy | ||||||||||
System | ||||||||||
Hospital, clinic, or | ||||||||||
intraoperative | ||||||||||
settings | Applicator | |||||||||
positioning, | ||||||||||
frequency and | ||||||||||
duration of | ||||||||||
treatments: flow and | ||||||||||
evacuation rate | Pressurized stream | |||||||||
and evacuation | ||||||||||
cuts, ablates, and | ||||||||||
removes tissue and | ||||||||||
foreign matter and | ||||||||||
surgically resects/ | ||||||||||
removes material | Irrigation/Suction | |||||||||
Nozzle | Pressurized Fluid | |||||||||
Stream & | ||||||||||
Evacuation | K991383 / K011612 | |||||||||
/ K060782 | Wound | |||||||||
debridement, soft | ||||||||||
tissue debridement, | ||||||||||
and cleansing of | ||||||||||
surgical site and | ||||||||||
burns | Smith & Nephew | |||||||||
(wound.smith- | ||||||||||
nephew.com/us/ | ||||||||||
Home.asp) VersaJet | ||||||||||
Hydrosurgery | ||||||||||
System |
807.92(a)(4)
Device Description
The AR1000 system uses ultrasound for selective tissue dissection and fragmentation and saline for irrigation of the wound bed over course of treatment.
807.92(a)(5)
Intended Use(s)
Selective dissection and fragmentation of tissue, wound debridement (acute and chro ic wounds, burns, diseased or necrotic tissue), and cleansing irrigation of the site for the remo al of debris, exudates, fragments, and other matter.
1
KO63544
ัวโป โยธิประกูตจังหวัดอันด์
国际官网官网官网 正版官
ຂວາງຂາຍອ່ວຂາຍປົວ ໄຂວigolourilวອT
:
スノニ
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/13 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized abstract design resembling a bird or human figure with outstretched arms. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the figure.
Public Health Service
JUL 2 2009
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Arobella Medical, LLC c/o Mr. Eliaz Babaev President & Chief Executive Officer 5929 Baker Road, Suite 470 Minnetonka, Minnesota 55345
Re: K062544
Trade/Device Name: AR1000 Ultrasonic Wound Therapy System Regulation Number: None Regulation Name: None Regulatory Class: Unclassified Product Code: LFL Dated: December 12, 2006 Received: December 13, 2006
Dear Mr. Babaev:
This letter corrects our substantially equivalent letter of January 3, 2007.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21, Parts 800 to 898. In addition. FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration
3
Page -Mr. Eliaz Babaev
and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to
http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/cdrh/mdr/ for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
ly yours,
I. Melkerson
Mark N. Melkerson Division of Surgical, Orthoped and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
4
Indications for Use
510(k) Number (if known): 长O62544
Device Name: AR1000 Ultrasonic Wound Therapy System
Indications for Use:
Selective dissection and fragmentation of tissue, wound debridement (acute and chronic wounds, burns, diseased or necrotic tissue), and cleansing irrigation of the site for the removal of debris, exudates, fragments, and other matter.
Prescription Use × (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
ಳ
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Sdo
DSP D.K
(Division Sign-Off) Division of General, Restorative, and Neurological Devices
510(k) Number L062544